반응식
S1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1([N:12]2[CH2:17][CH2:16][CH2:15][CH2:14][CH2:13]2)[CH2:11][CH2:10][CH2:9][CH2:8][CH2:7]1.CN[C@@H:20](C([O-])=O)[CH2:21]C([O-])=O>>[CH:5]1[CH:4]=[CH:3][C:2]([C:6]2([N:12]3[CH2:17][CH2:16][CH2:15][CH2:14][CH2:13]3)[CH2:11][CH2:10][CH2:9][CH2:8][CH2:7]2)=[CH:20][CH:21]=1참가 물질
3
실험 절차
N[1-(2-thienyl)cyclohexyl]piperidine (TCP); N-methyl-D-aspartate (NMDA); D(-)2-amino-5-phosphovaleric acid (AP-5); (+) 5 methyl-10,11 dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (dibenzocycloalkenimine) (MK-801).
출처 및 근거
- ORD 기록
- ord-fa883a65ba624b6a83309d68189a531b
- 출처 데이터셋
- uspto-grants-1991_02
- 특허 번호
- US04994446
연결된 노트
불러오는 중…